Pathologic prognostic factors in stage I–III uterine carcinosarcoma treated with postoperative radiotherapy

被引：0
作者：
Ángeles Rovirosa
Carlos Ascaso
Meritxell Arenas
Ivan Ríos
Marta del Pino
Jaume Ordi
Javier Morales
Marina Gascón
Jaume Pahisa
Albert Biete
机构：
[1] University of Barcelona,Gynecological Cancer Unit, Radiation Oncology Department, Hospital Clinic, ICMHO, IDIBAPS
[2] University of Barcelona,Epidemiology Unit, IDIBAPS
[3] Hospital Sant Joan de Reus,Radiation Oncology Department
[4] Hospital Clinic,Gynecological Cancer Unit, IGON
[5] University of Barcelona,Pathology Department, CRESIB (Centre de Recerca en Salut International), Hospital Clinic, Faculty of Medicine
来源：
Archives of Gynecology and Obstetrics | 2014年 / 290卷
关键词：
Carcinosarcomas; Radiotherapy; Prognostic factors; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：329 / 334
页数：5
相关论文
共 50 条
  • [21] Do conventional pathologic features lose their prognostic significance following postoperative radiation therapy in pathologic stage I-II endometrial adenocarcinoma?
    Mundt, AJ
    Connell, PP
    INTERNATIONAL JOURNAL OF CANCER, 2000, 90 (04) : 224 - 230
  • [22] Impact of Adjuvant Pelvic Radiotherapy in Stage I Uterine Sarcoma
    Magnuson, William J.
    Petereit, Daniel G.
    Anderson, Bethany M.
    Geye, Heather M.
    Bradley, Kristin A.
    ANTICANCER RESEARCH, 2015, 35 (01) : 365 - 370
  • [23] Multimodality adjuvant therapy and survival outcomes in stage I-IV uterine carcinosarcoma
    McEachron, Jennifer
    Heyman, Taryn
    Shanahan, Lisa
    Tran, Van
    Friedman, Monica
    Gorelick, Constantine
    Economos, Katherine
    Singhal, Pankaj K.
    Lee, Yi-Chun
    Kanis, Marguax J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (07) : 1012 - 1017
  • [24] Postoperative radiotherapy of spinal and intracranial ependymomas: analysis of prognostic factors
    Stuben, G
    Stuschke, M
    Kroll, M
    Havers, W
    Sack, H
    RADIOTHERAPY AND ONCOLOGY, 1997, 45 (01) : 3 - 10
  • [25] Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer®-accredited facilities
    Vaz, Jennifer
    Tian, Chunqiao
    Richardson, Michael T.
    Chan, John K.
    Mysona, David
    Rao, Uma N.
    Powell, Matthew A.
    Shriver, Craig D.
    Hamilton, Chad A.
    Casablanca, Yovanni
    Maxwell, G. Larry
    Darcy, Kathleen M.
    GYNECOLOGIC ONCOLOGY, 2020, 157 (01) : 121 - 130
  • [26] Prognostic factors in chordoma: Role of postoperative radiotherapy
    Thieblemont, C
    Biron, P
    Rocher, F
    Bouhour, D
    Bobin, JY
    Gerard, JP
    Blay, JY
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (13-14) : 2255 - 2259
  • [27] HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma
    Mizoguchi, Chiharu
    Nishikawa, Tadaaki
    Yoshida, Hiroshi
    Yasuda, Masanori
    Kato, Tomoyasu
    Hasegawa, Kosei
    Yonemori, Kan
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2025, 36 (01)
  • [28] Role of adjuvant radiotherapy modality on clinical outcomes for early-stage uterine carcinosarcoma
    Tyan, Kevin
    Liu, Kevin X.
    Smart, Alicia C.
    Feltmate, Colleen M.
    Horowi, Neil S.
    Muto, Michael G.
    Worley Jr, Michael J.
    Elias, Kevin M.
    Liu, Joyce F.
    Wright, Alexi A.
    Konstantinopoulos, Panagiotis A.
    Campos, Susana M.
    Matulonis, Ursula A.
    Franco, Idalid
    Le, Larissa J.
    King, Martin T.
    Dyer, M. Aiven
    GYNECOLOGIC ONCOLOGY, 2025, 195 : 75 - 81
  • [29] Prognostic factors in definitive radiotherapy of uterine cervical cancer
    Yalman, D
    Aras, AB
    Özkök, S
    Duransoy, A
    Çelik, ÖK
    Özsaran, Z
    Haydaroglu, A
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2003, 24 (3-4) : 309 - 314
  • [30] Prognostic Value of Radiotherapy and Chemotherapy in Stage I-III Merkel Cell Carcinoma
    Bi, Aihong
    Yang, Sifu
    Ding, Yang
    Yu, Yong
    Zhan, Wenming
    Song, Tao
    FRONTIERS IN MEDICINE, 2022, 9
12345